✦ LIBER ✦

CARDIOTOXICITY OF 5-FLUOROURACIL

✍ Scribed by LANGSTEVENSON, D

Book ID: 122881861
Publisher: The Lancet
Year: 1977
Tongue: English
Weight: 293 KB
Volume: 310
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(77)90339-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of 5 fluorouracil associated

Prevention of 5 fluorouracil associated cardiotoxicity

✍ DAVIDSON, J. A. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB

Symptomatic Cardiotoxicity Associated wi

Symptomatic Cardiotoxicity Associated with 5-Fluorouracil

✍ Dr. Christine C. Meyer; Dr. Karim Anton Calis; Ms. Laurie B. Burke; Ms. Cynthia 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 742 KB

The clinical syndrome of 5-fluorouracil

The clinical syndrome of 5-fluorouracil cardiotoxicity

✍ John F. Ensley; Bharat Patel; Robert Kloner; Julie A. Kish; Joshua Wynne; Muhyi 📂 Article 📅 1989 🏛 Springer US 🌐 English ⚖ 750 KB

5-fluorouracil (FUra) is one of the most frequently used drugs in cancer treatment, particularly in combination with other agents. Its activity when administered as an infusion rather than a bolus has led to a renewed and increased use. A cardiotoxicity that mimics ischemia has been associated with

Capecitabine (and 5 Fluorouracil) Cardio

Capecitabine (and 5 Fluorouracil) Cardiotoxicity. Metabolic Considerations

✍ Chiara Lestuzzi; Lucia Tartuferi; Giuseppe Corona 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB

The syndrome of 5-fluorouracil cardiotox

The syndrome of 5-fluorouracil cardiotoxicity: An elusive cardiopathy

✍ Norood R. Anderson; Jacob J. Lokich; Cherie Moore 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 1 views

Prophylactic options in patients with 5-

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

✍ Cianci, G; Morelli, M F; Cannita, K; Morese, R; Ricevuto, E; Di Rocco, Z C; Porz 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 72 KB